Current Protein Identity:P01019 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1N9U Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship Deposited 2002-11-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–43(10 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions 298 K;Pressure ambient
NMR sample composition 2.5 mM; DMSO-d6 | DMSO-d6
Resolution not provided
1N9V Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship. Deposited 2002-11-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–41(8 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions 298 K;Pressure ambient
NMR sample composition 2.5 mM; DMSO-d6 | DMSO-d6
Resolution not provided
2JP8 Angiotensin 1-7 Deposited 2007-04-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain P 34–40(7 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 2.9;278 K;Ionic strength (raw mmCIF value) 12;Pressure ambient
NMR sample composition 12.0 mM angiotensin, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
2WXW Crystal structure of human angiotensinogen Deposited 2009-11-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–485(452 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;2-2.5N NACL, 0.2M CACL2, 0.1M TRIS-HCL, PH8
Resolution 3.30 Å R-free 0.318
2X0B Crystal structure of human angiotensinogen complexed with renin Deposited 2009-12-08 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 34–485(452 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;1.6-2.2M AS, 0.1M MES, PH6
Resolution 4.33 Å R-free 0.334
2X0B Crystal structure of human angiotensinogen complexed with renin Deposited 2009-12-08 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 34–485(452 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;1.6-2.2M AS, 0.1M MES, PH6
Resolution 4.33 Å R-free 0.334
2X0B Crystal structure of human angiotensinogen complexed with renin Deposited 2009-12-08 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 34–485(452 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;1.6-2.2M AS, 0.1M MES, PH6
Resolution 4.33 Å R-free 0.334
2X0B Crystal structure of human angiotensinogen complexed with renin Deposited 2009-12-08 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain H 34–485(452 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;1.6-2.2M AS, 0.1M MES, PH6
Resolution 4.33 Å R-free 0.334
4AA1 Crystal structure of ANCE in complex with Angiotensin-II Deposited 2011-11-30 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain P 34–41(8 aa)
Not recorded ZN ZINC ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;0.1 M HEPES 7.5, 1.3 M SODIUM CITRATE
Resolution 1.99 Å R-free 0.211
4APH Human angiotensin-converting enzyme in complex with angiotensin-II Deposited 2012-04-03 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain P 34–41(8 aa)
Not recorded CL CHLORIDE ION × 2 ZN ZINC ION × 1 PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ACT ACETATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.7;50MM SODIUM ACETATE PH 4.7, 16% PEG4000, 10UM ZNSO4
Resolution 1.99 Å R-free 0.240
4FYS Human aminopeptidase N (CD13) in complex with angiotensin IV Deposited 2012-07-05 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 36–41(6 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 SO4 SULFATE ION × 11 X-RAY DIFFRACTION
X-ray crystallization conditions hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
Resolution 2.01 Å R-free 0.198
5E2Q Structure of human DPP3 in complex with angiotensin-II Deposited 2015-10-01 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 34–41(8 aa) Fragment:UNP residues 34-41
Not recorded MG MAGNESIUM ION × 1 K POTASSIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.2;293 K;0.056 M sodium phosphate monobasic monohydrate, 1.344 M potassium phosphate dibasic monohydrate
Resolution 2.40 Å R-free 0.247
5M3X Crystal structure of human angiotensin I-deleted angiotensinogen Deposited 2016-10-17 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 44–485(442 aa)
Mutation:N137Q, N271Q, N295Q, C232S, C308S No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;1.7M Ammonium Sulfate, 0.1M Citric Acid, pH3.6
Resolution 2.63 Å R-free 0.282
5M3X Crystal structure of human angiotensin I-deleted angiotensinogen Deposited 2016-10-17 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 44–485(442 aa)
Mutation:N137Q, N271Q, N295Q, C232S, C308S No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;1.7M Ammonium Sulfate, 0.1M Citric Acid, pH3.6
Resolution 2.63 Å R-free 0.282
5M3Y Crystal structure of human glycosylated angiotensinogen Deposited 2016-10-17 Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–485(452 aa)
Mutation:N137Q, N271Q, N295Q, C232S, C308S No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;2.0M Ammonium Sulfate, 0.1M Bicine, pH9.0
Resolution 2.30 Å R-free 0.189
6I3F Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom Deposited 2018-11-06 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 34–485(452 aa)
Mutation:N137Q, N271Q, N295Q,C232S,C308S SO4 SULFATE ION × 10 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.6;293 K;1.76M Ammonium sulfate 0.1M Tris, pH7.6
Resolution 2.55 Å R-free 0.234
6I3I Crystal structure of reactive center loop (RCL) cleaved angiotensinogen Deposited 2018-11-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–485(452 aa)
Mutation:N137Q,N271Q,N295Q,C232S,C308S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;1.5M ammonium sulfate, 0.1M Tris pH8.5 12% glycerol
Resolution 2.97 Å R-free 0.237
6OS0 Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II Deposited 2019-05-01 Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 34–41(8 aa) Fragment:residues 34-41
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 7.6;293 K;Protein complex was reconstituted with a 10:1 (w/w) mixture of monoolein and cholesterol. Crystals were grown in 100 mM Tris pH 7.6, 10 mM MgCl2, 25-26% PEG 300
Resolution 2.90 Å R-free 0.318